Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
about
sameAs
Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivoCancer: fundamentals behind pH targeting and the double-edged approachAlterations in Red Blood Cell Functionality Induced by an Indole Scaffold Containing a Y-Iminodiketo Moiety: Potential Antiproliferative ConditionsThe divergence, actions, roles, and relatives of sodium-coupled bicarbonate transportersEffect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation.Atrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulatorsExpression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44A simple and effective "capping" approach to readily tune the fluorescence of near-infrared cyaninesMonocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.Ultra-pH-sensitive nanoprobe library with broad pH tunability and fluorescence emissions.Design and investigation of a series of rhodamine-based fluorescent probes for optical measurements of pH.Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty?An acidic environment changes cyclin D1 localization and alters colony forming ability in gliomas.Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer questionTumor metabolism, cancer cell transporters, and microenvironmental resistance.Identifying an uptake mechanism for the antiepileptic and bipolar disorder treatment valproic acid using the simple biomedical model Dictyostelium.Naphthalene diimides as red fluorescent pH sensors for functional cell imaging.Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL MicroenvironmentAlterations of intracellular pH homeostasis in apoptosis: origins and roles.Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer.Evidence-based support for the use of proton pump inhibitors in cancer therapyThe mechanostability of isolated focal adhesions is strongly dependent on pHTumor acidity, chemoresistance and proton pump inhibitors.Anticancer agents that counteract tumor glycolysis.In Vivo Loss of Function Screening Reveals Carbonic Anhydrase IX as a Key Modulator of Tumor Initiating Potential in Primary Pancreatic Tumors.Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targetspH-sensitive fluorescent dyes: are they really pH-sensitive in cells?Stable DNA Nanomachine Based on Duplex-Triplex Transition for Ratiometric Imaging Instantaneous pH Changes in Living Cells.Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?Quantum dot-fluorescent protein FRET probes for sensing intracellular pHVoltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells.A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors.A ratiometric pH reporter for imaging protein-dye conjugates in living cellsCariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research.Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor statusA protein-dye hybrid system as a narrow range tunable intracellular pH sensor.MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.
P2860
Q24675613-8B32F2CB-3B8D-4A12-8298-5B289D18AE39Q28821351-DF670978-8FBA-4977-B575-0074F00AEDECQ28830527-3F1BF300-FDE3-4FD2-9F6F-3AF633124754Q30440948-44C1B6B2-EFD7-4853-8CDA-ADA07878D9D0Q31129007-7821B818-FCC0-4423-A628-8B0E8DE148B1Q33641532-DD8CE7A8-F1A8-45C4-A289-9EEBBFA4BFB8Q33777106-CC515E39-9A06-45AE-9D91-C0625BAD5A02Q33824543-8CF31A8C-FE3D-40AD-864D-F533341C29D9Q33877912-275A5BDE-803C-405E-A8EE-1E7370735E53Q33970452-8F4F5A1F-CDBB-4963-A977-89327F21CDA2Q34045478-6A13FDE0-DD4D-446E-A019-30238A2D8DE3Q34077584-E1E928B6-298F-4EA2-B2B7-24C3708C50EEQ34182861-BE9CC54D-FDD6-4182-8CEE-7FB716839DF5Q34374920-7EF14590-ACBE-402A-9539-E707EBD0BC8AQ34459681-2F994E06-5F5B-42D9-A45C-907D2C2AB76FQ34513382-27F431E3-4495-404B-87E9-D8681983FAD6Q35041292-C6FC4DC4-17B5-430C-BC74-6323925F80AEQ35404062-81A9B91D-13A0-47E8-A297-9780F7B440E9Q35606359-606F4E78-0715-4C49-BBF2-A261A270466EQ35803867-5DCE09A7-F502-4710-9908-E6049659C251Q36224507-5F3F3230-ABB4-4AA9-8B82-2454ADFC53B3Q36310900-28236FC0-0758-4005-B01F-281898270B62Q36334767-E6895FE2-FBEB-4763-833D-83E6B7A2F26CQ36429624-A30DCFCA-80C4-4A7E-9860-C17A13268F3DQ36452381-5961D301-5132-4382-89F4-C168B2FD61FCQ36480199-DAA0903D-4786-4838-8E8A-4DD4F57EED34Q36544108-5F6CA9DE-CEB0-4E89-9C6E-232DC27CDBAFQ36824105-5A9BDD80-B559-48C1-9B48-FE9947B4221EQ37055291-47FC64BD-5DE5-414E-96B4-43D4BF6185E3Q37081252-2E4DE3C7-5CCA-471F-A0B9-13995DD37F4CQ37132414-57A6D32F-A8D4-4CF4-ABFC-EB2520565388Q37136701-1AE73718-6638-46B5-9829-4592A6DCB81AQ37136807-86972FE6-DDD4-4A05-A843-DFE7D2BC1526Q37152857-745D5863-7F2D-472A-8986-7734AA1386B3Q37289136-280F7820-8633-406F-885E-741DBF835D3DQ37304956-698D89DD-D32A-471A-91FF-C2DA11FBF9E8Q37306101-98D99E96-FCFF-457B-AE0B-22F6CBBE3D3EQ37467710-1F5F628E-59BA-484C-B1F4-20D6A20DE9A9Q37536613-9BA34C6C-DEDF-4980-83CD-2B72949844FAQ37564738-64D938C0-94D6-4A4B-A3AD-958AA0178FB8
P2860
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
@ast
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
@en
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
@nl
type
label
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
@ast
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
@en
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
@nl
prefLabel
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
@ast
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
@en
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
@nl
P2093
P3181
P1476
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
@en
P2093
Hidetaka Uramoto
Hiroshi Ishiguchi
Hiroto Izumi
Kimitoshi Kohno
Minoru Nomoto
Mizuho Tanabe
Tadashi Murakami
Takayuki Torigoe
Takeshi Yoshida
Tomoko Ise
P3181
P356
10.1016/S0305-7372(03)00106-3
P407
P577
2003-12-01T00:00:00Z